Man Group PLC Rhythm Pharmaceuticals, Inc. Transaction History

Man Group PLC

  • $36 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$15.81 - $27.8 $177,072 - $311,360
11,200 New
11,200 $256,000
Q4 2018

Feb 14, 2019
SELL
$24.11 - $31.34 $1.36 Million - $1.77 Million
-56,360 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$26.99 - $35.85 $1.52 Million - $2.02 Million
56,360 New
56,360 $1.64 Million

Others Institutions Holding RYTM

# of Institutions
191
Shares Held
67.3M
Call Options Held
834K
Put Options Held
78.6K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.1B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email